Cargando…

Estimation of metabolite T(1) relaxation times using tissue specific analysis, signal averaging and bootstrapping from magnetic resonance spectroscopic imaging data

Object A novel method of estimating metabolite T(1) relaxation times using MR spectroscopic imaging (MRSI) is proposed. As opposed to conventional single-voxel metabolite T(1) estimation methods, this method investigates regional and gray matter (GM)/white matter (WM) differences in metabolite T(1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratiney, H., Noworolski, S. M., Sdika, M., Srinivasan, R., Henry, R. G., Nelson, S. J., Pelletier, D.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798973/
https://www.ncbi.nlm.nih.gov/pubmed/17602253
http://dx.doi.org/10.1007/s10334-007-0076-0
Descripción
Sumario:Object A novel method of estimating metabolite T(1) relaxation times using MR spectroscopic imaging (MRSI) is proposed. As opposed to conventional single-voxel metabolite T(1) estimation methods, this method investigates regional and gray matter (GM)/white matter (WM) differences in metabolite T(1) by taking advantage of the spatial distribution information provided by MRSI. Material and methods The method, validated by Monte Carlo studies, involves a voxel averaging to preserve the GM/WM distribution, a non-linear least squares fit of the metabolite T(1) and an estimation of its standard error by bootstrapping. It was applied in vivo to estimate the T(1) of N-acetyl compounds (NAA), choline, creatine and myo-inositol in eight normal volunteers, at 1.5 T, using a short echo time 2D-MRSI slice located above the ventricles. Results WM-T(1,NAA) was significantly (P < 0.05) longer in anterior regions compared to posterior regions of the brain. The anterior region showed a trend of a longer WM T(1) compared to GM for NAA, creatine and myo-Inositol. Lastly, accounting for the bootstrapped standard error estimate in a group mean T(1) calculation yielded a more accurate T(1) estimation. Conclusion The method successfully measured in vivo metabolite T(1) using MRSI and can now be applied to diseased brain.